Tricare Wegovy Coverage: Military Health System Rules for Weight-Loss Drugs

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 11 sources cited · As of May 2026, confirm directly with your plan

Key Takeaways

• Tricare covers Wegovy through the Tricare Pharmacy Program with PA when criteria are met
• Express Scripts administers the Tricare Pharmacy Program under DoD contract
• Active duty service members face additional considerations around fitness and operational readiness
• Cost-sharing varies by beneficiary category and pharmacy choice (military, mail order, retail network)
• The March 2024 cardiovascular indication and December 2024 OSA indication (for Zepbound) opened additional coverage pathways

Direct answer

Tricare covers Wegovy for eligible beneficiaries through the Tricare Pharmacy Program administered by Express Scripts. Coverage requires prior authorization with BMI documentation, comorbidity evidence, and demonstrated failed lifestyle intervention. Coverage extends to active duty service members, retirees, and dependents enrolled in Tricare. Cost-sharing depends on beneficiary category and pharmacy choice. The March 2024 cardiovascular indication provides an alternative pathway. Verify with Tricare and Express Scripts directly.

Table of contents

1. The Tricare Pharmacy Program structure
2. Beneficiary categories and eligibility
3. Wegovy PA criteria under Tricare
4. Active duty service member considerations
5. Pharmacy options and cost-sharing
6. The cardiovascular indication pathway
7. Tricare for Life and Medicare interaction
8. Humana Military's administrative role
9. Appealing a Tricare denial
10. Decision framework
11. FAQ
12. Sources

The Tricare Pharmacy Program structure

Tricare provides healthcare coverage to active duty service members, military retirees, and their dependents through programs managed by the Defense Health Agency (DHA). The Tricare Pharmacy Program is the prescription drug component.

Express Scripts has held the Tricare Pharmacy Program contract for many years, administering:

• Pharmacy benefit management for the entire Tricare population
• Tricare Pharmacy Home Delivery (mail order)
• Retail pharmacy network administration
• Prior authorization processing
• Clinical management programs

The Tricare formulary is determined by the Defense Department's Pharmacy and Therapeutics Committee, not by Express Scripts directly. Express Scripts administers the formulary the DoD designed.

Beneficiary categories and eligibility

Tricare beneficiaries fall into several categories:

• Active duty service members
• Active duty family members (spouses and children)
• Military retirees and their families
• Tricare for Life beneficiaries (Medicare-eligible retirees with Tricare wraparound)
• Tricare Reserve Select members (drilling reservists)
• Survivors of deceased service members
• Medal of Honor recipients and certain other categories

Each category has different cost-sharing rules. Active duty service members typically have no out-of-pocket cost for covered medications. Retirees and dependents have small copays.

Wegovy PA criteria under Tricare

Tricare PA for Wegovy generally requires:

1. BMI 30 or higher, or BMI 27 with weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea)
2. Documentation of failed lifestyle intervention attempts, typically 6 months
3. Absence of contraindications (personal or family history of medullary thyroid carcinoma, MEN 2 syndrome)
4. Documentation of medical necessity by prescribing clinician
5. Sometimes, prior trial of alternative anti-obesity medication

Initial PA approval is typically 6 months with reauthorization requiring documented clinical response (typically 5% or more weight loss).

Active duty service member considerations

Active duty service members face specific considerations:

• Military fitness standards (body fat, waist measurement, physical fitness tests)
• Deployment readiness and operational fitness requirements
• Service-specific weight management programs (Army's ACFT, Navy/Marine Corps body composition standards, Air Force BCAP)
• Command medical officer awareness of medication use

While Wegovy is not on the DoD prohibited medications list, weight-management medication use intersects with operational readiness in ways that civilian patients do not experience. Service members should discuss with their command medical officer to understand any duty or deployment implications.

For service members whose BMI or body composition has prompted command intervention, Wegovy can be part of a clinically supervised weight-management plan with concurrent service-specific program participation.

Pharmacy options and cost-sharing

Tricare beneficiaries can fill prescriptions through three pathways:

Pharmacy option	Cost (non-active-duty)
Military Treatment Facility (MTF) pharmacy	$0 for formulary medications
Tricare Pharmacy Home Delivery (90-day supply)	Generic $14, brand formulary $38, brand non-formulary $76 (approximate, subject to annual adjustment)
Tricare network retail (30-day supply)	Generic $16, brand formulary $43, brand non-formulary $76 (approximate)
Out-of-network retail	Higher cost-sharing, often partial reimbursement

Active duty service members pay $0 at all Tricare network pharmacies. Specific copay amounts are updated by the DoD annually; check current Tricare Pharmacy Program cost-sharing schedules.

The Tricare Pharmacy Home Delivery option through Express Scripts often produces the lowest cost-sharing for maintenance medications like Wegovy. The 90-day supply structure reduces refill frequency.

The cardiovascular indication pathway

The March 2024 FDA approval of Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease and overweight or obesity has been incorporated into Tricare coverage policy. The approval was based on the SELECT trial (Lincoff et al., New England Journal of Medicine 2023), enrolling 17,604 patients.

For Tricare beneficiaries with established atherosclerotic cardiovascular disease, the CV indication provides an additional coverage pathway. Requirements typically include:

• Documented atherosclerotic CVD (prior MI, prior stroke, or angiographically confirmed CAD)
• BMI 27 or higher
• Cardiology consultation or co-signature
• Sometimes, documented statin and other cardiovascular therapy

Tricare for Life and Medicare interaction

Tricare for Life beneficiaries are Medicare-eligible retirees with Tricare wraparound coverage. Their primary prescription drug coverage is Medicare Part D, with Tricare acting as secondary payer for cost-sharing.

For Wegovy, this creates a complex coverage interaction:

• Medicare Part D generally excludes weight-loss medications
• The March 2024 CV indication created a Part D coverage path for established CVD
• Tricare wraparound can cover cost-sharing on Part D-covered drugs
• For drugs Part D does not cover, Tricare for Life does not generally provide alternative coverage

Tricare for Life beneficiaries seeking Wegovy should pursue the CV indication when applicable and coordinate between Part D plan and Tricare for cost-sharing.

Humana Military's administrative role

Humana Military administers Tricare East Region under contract with the Department of Defense, handling medical claims and member services. Humana Military does not directly determine Tricare drug formulary; Express Scripts handles pharmacy benefit administration and the DoD P&T Committee designs the formulary.

Beneficiaries in the East Region (most of the eastern United States) interact with Humana Military for medical coverage questions but with Express Scripts for prescription coverage. The two systems coordinate through Tricare's overall structure but operate as separate contractors.

Appealing a Tricare denial

Tricare pharmacy appeals proceed through:

1. Internal Express Scripts review of denial
2. Reconsideration request to Express Scripts with additional clinical documentation
3. Appeal to the Defense Health Agency for final administrative review

Each step has specific deadlines. Standard appeals typically must be filed within 90 days of denial. Expedited appeals are available for urgent cases.

For Wegovy appeals:

• Document BMI history and comorbidities thoroughly
• Include lifestyle intervention attempts with specific timeline
• For CV indication: include cardiology documentation and SELECT trial citation
• If service member: discuss with command medical officer for support

Decision framework

If you are an active duty service member with BMI 30+ or 27+ with comorbidities: Submit PA through your military physician. Coordinate with command medical officer regarding readiness implications.

If you are a retiree, dependent, or other Tricare beneficiary: Standard PA pathway through your Tricare-network physician. Use Tricare Pharmacy Home Delivery for lowest cost-sharing.

If you have established cardiovascular disease: Pursue the CV indication, which has its own PA pathway and broader applicability than obesity criteria alone.

If you are Tricare for Life: Coordinate between Medicare Part D plan and Tricare wraparound. The CV indication is your most accessible pathway.

If denied: File reconsideration through Express Scripts. Appeal to DHA. Strengthen documentation for OSA, CV, or obesity indication as applicable.

What to verify before using this answer

The useful next step for Tricare Wegovy Coverage: Military Health System Rules for Weight-Loss Drugs is to verify the details that can change the decision: current labeling, insurance rules, pharmacy instructions, dose timing, contraindications, and whether the evidence applies to your diagnosis rather than only to weight loss headlines.

For this coverage and access page, the most relevant search terms are does, tricare, cover, wegovy. Those terms point to a practical decision, so the answer should be checked against a current prescription label, payer policy, trial result, or clinician recommendation before you act.

FormBlends keeps this page focused on patient-level decision points: what is known, what is uncertain, what should be handled by a licensed clinician, and what should be avoided because it creates dosing, safety, or access risk.

FAQ

Does Tricare cover Wegovy? Yes, with PA for eligible beneficiaries meeting criteria.

Who administers Tricare prescription benefits? Express Scripts under DoD contract.

What is the Tricare prior authorization for Wegovy? BMI, comorbidities, failed lifestyle intervention, absence of contraindications.

How much does Wegovy cost with Tricare? Active duty $0. Others approximately $14 to $76 depending on pharmacy choice.

Are there active-duty considerations for Wegovy? Operational readiness intersections; discuss with command medical officer.

Does Tricare cover Wegovy for heart disease? Yes, CV indication has been incorporated.

Can dependents use Wegovy through Tricare? Yes, same PA criteria as sponsor service members.

What is the appeals process? Express Scripts internal review, DHA appeal.

Sources

1. FDA, Wegovy (semaglutide) prescribing information, cardiovascular indication, March 2024
2. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine. November 2023
3. Wilding JPH et al. STEP 1 trial. New England Journal of Medicine. 2021
4. Tricare Pharmacy Program Formulary, administered by Express Scripts, 2026
5. Defense Health Agency, Tricare beneficiary handbook
6. Department of Defense, Tricare cost-sharing schedule, 2026
7. DoD Pharmacy and Therapeutics Committee, GLP-1 coverage policies
8. Humana Military, Tricare East Region administration materials
9. Centers for Medicare and Medicaid Services, Part D and Tricare for Life coordination guidance
10. Novo Nordisk, Wegovy prescribing information and clinical data
11. Service-specific weight management program publications (Army, Navy, Air Force, Marine Corps, Space Force)

Footer disclaimers

Platform Disclaimer. FormBlends is a telehealth platform connecting patients with licensed clinicians and 503A compounding pharmacy partners. FormBlends is not affiliated with Tricare, the Department of Defense, Defense Health Agency, Express Scripts, Humana Military, or Novo Nordisk. Coverage information reflects publicly available data as of May 2026.

Compounded Medication Notice. Compounded semaglutide is a 503A pharmacy product, not FDA-approved, and not interchangeable with brand-name Wegovy. Tricare does not cover compounded medications. Active duty service members should consult command medical officer before using compounded medications.

Results Disclaimer. Weight loss and cardiovascular outcomes from clinical trial data reflect average effects in study populations. Individual response varies by dose tolerability, adherence, and baseline status. Service members should be aware that medication use is one component of overall fitness and readiness considerations.

Trademark Notice. Wegovy is a registered trademark of Novo Nordisk A/S. Tricare is a registered service mark of the United States Department of Defense. Express Scripts is a registered trademark of Express Scripts Holding Company. Humana Military is operated by Humana, Inc. References are informational.